Uncertain Futures: Individual Risk and Social Context in Decision-Making in Cancer Screening.

Department of Clinical Sciences Division of Ethics & Health Policy University of Texas Southwestern Medical Center at Dallas, USA.
Health Risk & Society (Impact Factor: 1.13). 04/2010; 12(2):101-117. DOI: 10.1080/13698571003637048
Source: PubMed

ABSTRACT A core logic of cancer control and prevention, like much in public health, turns on the notion of decision-making under conditions of uncertainty. Population-level data are increasingly used to develop risk profiles, or estimates, that clinicians and the consumer public may use to guide individual decisions about cancer screening. Individual risk perception forms a piece of a larger social economy of decision-making and choice that makes population screening possible. Individual decision-making depends on accessing and interpreting available clinical information, filtered through the lens of personal values and both cognitive and affective behavioral processes. That process is also mediated by changing social roles and interpersonal relationships. This paper begins to elucidate the influence of this "social context" within the complexity of cancer screening. Reflecting on current work in risk and health, I consider how ethnographic narrative methods can enrich this model.


Available from: Simon J Craddock Lee, Feb 17, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Breast screening with mammography can be contentious because of its unintended harmful repercussions. A false-positive mammography is one of the most frequent harms and can encompass both short- and long-term psychosocial implications. Based on eight qualitative in-depth interviews with women who reported negative psychosocial consequences following a false-positive mammography, this article explores how women in the study experienced having a false-positive and how these experiences manifested themselves in a long-term perspective. This article draws on data from in-depth interviews with eight women in Denmark, in 2009, who had had false positive screening results approximately 5 years before the interview. Despite all participants having a self-perception of low risk of breast cancer, they regularly participated in screening. When receiving the recall letter and in the interim, the women perceived themselves as and identified with cancer patients and feared dying. When further investigation indicated that they did not have cancer, the women in the study treated this as an acquittal and expressed gratitude for the screening programme. However, their confrontation with an initial positive breast cancer diagnosis created concerns that the women still experienced and had to manage 4 to 5 years after the initial false-positive mammography. We argue that the psychosocial consequences of having the false-positive mammography contributed to the women’s view of themselves as being subjects at constant risk. However, the women did not blame the medical technology for its inaccuracy and inflicted worries, and the false-positive mammography did not lead to them losing confidence in screening. The women in the study strove for means to control the latent anxiety that was introduced with the false-positive mammography, by continuously seeking medical confirmation of their well-being and desiring more frequent screening.
    Health Risk & Society 12/2013; 15(8). DOI:10.1080/13698575.2013.848845 · 1.13 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The increasing global prevalence of type 2 diabetes has given rise to numerous trials designed to preventing diabetes. Most of these trials focus on encouraging individuals, especially ‘high-risk’ individuals to make lifestyle changes to reduce their chance of developing diabetes. Based on group interviews with health care professionals and qualitative in-depth interviews with participants in a diabetes preventive intervention with a biomedical aim to reduce risk of diabetes, in this article I critically explore the transformative potential of the medical classification prediabetes. My analysis of these data was informed by Bourdieu’s theory of practice and his concept of habitus which he defined as ‘systems of durable, transposable dispositions, structured structures predisposed to function as structuring structures, that is, as principles which generate and organise practices and representations’. Health professionals especially doctors saw the categorisation of patients as prediabetic in biomedical terms as a technical exercise that made visible information that already existed. In contrast, I found that patients saw the categorisation as creating a more fundamental change, the making of a new ‘high-risk’ person who had to take action based on a dialectical interplay between freedom and constraint in their everyday life, to manage these risk factors. They defined themselves as having a medical condition, a ‘lifestyle disease’. For these individuals, the precise meaning of and potential course of action depended on context, for example being diagnosed with prediabetes, could lead to personal benefits for those who were able to lower their blood glucose level. However, for some, there were circumstances, such as genetics, age or race, which could be neither influenced nor controlled. In this article, I note that screening-based preventive interventions that fail to consider embodied social knowledge and lived experiences will not achieve their desired outcomes.
    Health Risk & Society 10/2014; DOI:10.1080/13698575.2014.969688 · 1.13 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background The perception of breast cancer risk held by women who have not had breast cancer, and who are at increased, but unexplained, familial risk of breast cancer is poorly described. This study aims to describe risk perception and how it is related to screening behaviour for these women. Methods Participants were recruited from a population-based sample (the Australian Breast Cancer Family Study - ABCFS). The ABCFS includes women diagnosed with breast cancer and their relatives. For this study, women without breast cancer with at least one first- or second-degree relative diagnosed with breast cancer before age 50 were eligible unless a BRCA1 or BRCA2 mutation had been identified in their family. Data collection consisted of an audio recorded, semi-structured interview on the topic of breast cancer risk and screening decision-making. Data was analysed thematically. Results A total of 24 interviews were conducted, and saturation of the main themes was achieved. Women were classified into one of five groups: don't worry about cancer risk, but do screening; concerned about cancer risk, so do something; concerned about cancer risk, so why don't I do anything?; cancer inevitable; cancer unlikely. Conclusions The language and framework women use to describe their risk of breast cancer must be the starting point in attempts to enhance women's understanding of risk and their prevention behaviour.
    Hereditary Cancer in Clinical Practice 09/2011; 9(1):7. DOI:10.1186/PREACCEPT-3415208745291659 · 1.71 Impact Factor